Anika Therapeutics completes Parcus Medical acquisition

Anika Therapeutics on Jan. 24 acquired privately-held sports medicine company Parcus Medical.

Advertisement

Three insights:

1. Anika acquired all membership interests for $35 million with $60 million in potential incentives.

2. Parcus Medical’s product portfolio facilitates surgeries of the shoulder, knee, hip and distal extremities.

3. The acquisition grants Anika access to the ASC market, which may lead to new revenue streams.

More articles on devices:
Bundled payments in spine: 12 key thoughts for 2020
Should pain management physicians perform endoscopic spine surgery? 8 spine specialists discuss
Medtronic CEO Omar Ishrak becomes Intel board chairman: 4 details

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.